Taro Pharmaceutical
TARO
$24.35
Share price
1.12%
Change (1 day)
-46.25%
Change (1 year)
Earnings for Taro Pharmaceutical (TARO)
Earnings in 2022 (TTM): $20.03 M
According to Taro Pharmaceutical's latest financial reports the company's current earnings (TTM) are $20.03 M. In 2021 the company made an earning of -$0.4 B a decrease over its 2020 earnings that were of $0.21 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Taro Pharmaceutical from 2001 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $20.03 M | -105.1% |
| 2021 | -$0.4 B | -281.6% |
| 2020 | $0.21 B | -34.33% |
| 2019 | $0.32 B | 17.96% |
| 2018 | $0.27 B | -26.03% |
| 2017 | $0.37 B | -38.75% |
| 2016 | $0.61 B | -4.59% |
| 2015 | $0.64 B | 33.56% |
| 2014 | $0.48 B | 19.73% |
| 2013 | $0.40 B | 21.53% |
| 2012 | $0.33 B | 51.79% |
| 2011 | $0.21 B | 145.87% |
| 2010 | $89.13 M | 25.9% |
| 2009 | $70.79 M | |
| 2005 | $16.83 M | -3356.09% |
| 2004 | -$0.52 M | -100.69% |
| 2003 | $74.68 M | 40.23% |
| 2002 | $53.25 M | 62.5% |
| 2001 | $32.77 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.00 B | 109,707.35% | 🇺🇸 USA |
 Novartis NVS | $8.37 B | 41,679.80% | 🇨🇭 Switzerland |
 Pfizer PFE | $35.96 B | 179,416.87% | 🇺🇸 USA |
 Merck MRK | $17.40 B | 86,773.63% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.60 B | 37,839.71% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$2.14 B | -10,760.81% | 🇮🇱 Israel |